ALK-IN-29 (compound 4c) has a certain inhibitory effect on tyrosine protein kinases ALK, CDK2/CyclinE1 and FAK, among which the strongest inhibitory effect on ALK kinase is 40.63% at a concentration of 10 µM. ALK-IN-29 can be used for anti-cancer research[1].
Molecular Weight:
457.58
Formula:
C29H32FN3O
Target:
Anaplastic lymphoma kinase (ALK),CDK,FAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
